INVESTOR PRESENTATION - MAYNE PHARMA GROUP LIMITED
MAYNE PHARMA GROUP LIMITED
Health Care
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Market Cap
596.07m
Price at Close
$0.355
4w avg. Volume
3.21m
4w avg. Turnover
$1.27m
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| +1.16% | 07 Jul 2020 |
| +4.71% | 05 Jul 2020 |
| -1.35% | 23 Jun 2020 |
| -2.67% | 15 Jun 2020 |
| -14.77% | 11 Jun 2020 |
| +4.49% | 03 Jun 2020 |
| +4.71% | 01 Jun 2020 |
| -2.30% | 28 May 2020 |
| -1.11% | 25 May 2020 |
| +14.49% | 15 Apr 2020 |
Market Data
Current Price
$0.355
52WK HIGH
$0.645
52WK LOW
$0.195
1YR RETURN
-26.80%
1YR RETURN VS. SECTOR
-48.93%
90 DAY RETURN
-16.47%
ASX RANK
321
/2,032
SECTOR RANK
1
/32
SHARES OUTSTANDING
1.68b
MAYNE PHARMA GROUP LIMITED
Health Care
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Market Cap
596.07m
Price at Close
$0.355
4w avg. Volume
3.21m
4w avg. Turnover
$1.27m
ASX:MYX is not raising right now
Want to invest?
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Contact Us
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia
(03) 9028 2888
deals@freshequities.com
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.